Steve Migausky joined Cardurion in March 2023 as Senior Vice President and General Counsel. Mr. Migausky has 15 years of experience guiding biotechnology companies on complex legal issues, transactions and corporate strategy. Mr. Migausky joined Cardurion from Imara, Inc., where he served as General Counsel and a member of the Executive Committee from Imara’s initial public offering through its merger with Enliven Therapeutics.
Prior to Imara, he served as General Counsel at Arqule, Inc., a publicly traded company, where he served as a key advisor in the company’s acquisition by Merck for $2.7 billion. Previously, he served in roles of increasing responsibility at Vertex Pharmaceuticals where he was responsible for SEC reporting and corporate law.
Mr. Migausky began his legal career as a corporate attorney at Wilmer Cutler Pickering Hale and Dorr LLP. Mr. Migausky holds a B.A. in economics and history from Colby College and a J.D. from the Georgetown University Law Center.